Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to improve clinical outcomes
August 30, 2023 17:00 ET
|
Medigene AG
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard) is an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors. Prof....
Medigene Expands Intellectual Property Rights for its Costimulatory Switch Proteins to Additional Immune Cell Types
August 23, 2023 08:00 ET
|
Medigene AG
Planegg/Martinsried, August 23, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Medigene AG to present at the 8th CAR-TCR Summit in Boston
August 22, 2023 10:00 ET
|
Medigene AG
Planegg/Martinsried, August 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for...
Foundery Launches Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies
August 22, 2023 07:30 ET
|
Foundery Innovations
SAN FRANCISCO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, today announced an initial closing of...
Immunology Market Size to Surpass USD 184.21 Billion in 2030, exhibiting a CAGR of 8.5%
August 22, 2023 05:03 ET
|
Fortune Business Insights
Pune, India, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Immunology Market Size was valued at USD 97.93 billion in 2021 and is projected to USD 184.21 billion by 2029, exhibiting a CAGR of 8.5%...
Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update
August 17, 2023 02:00 ET
|
Medigene AG
Pipeline expansion into neoantigens with multiple KRAS mutations as the first targets Acquired exclusive, worldwide rights to a CD40L-CD28 costimulatory switch protein Data from MDG1015 and multiple...
Medigene to participate in the H.C. Wainwright Immune Cell Engager Virtual Conference
August 16, 2023 14:30 ET
|
Medigene AG
Planegg/Martinsried, August 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for...
Medigene AG to report Second Quarter and Six Months 2023 Financial Results and Corporate Update on August 17, 2023
August 10, 2023 11:30 ET
|
Medigene AG
Planegg/Martinsried, August 10, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Plasma Fractionation Market revenue to exceed USD 37 Billion by 2033, says Research Nester
July 31, 2023 06:00 ET
|
Research Nester
New York, July 31, 2023 (GLOBE NEWSWIRE) -- The global plasma fractionation market size is slated to expand at ~7% CAGR between 2023 and 2033. The market is poised to garner a revenue of USD 37...
[Latest] Global Precision Medicine Market Size/Share Worth USD 189.64 Billion by 2030 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 20, 2023 11:30 ET
|
Custom Market Insights
Austin, TX, USA, July 20, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Precision Medicine Market Size, Trends and Insights By Technology (Big data...